Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c level

Diabetic Medicine

Volumn 31, Issue 4, 2014, Pages 466-471

  Urbanova J ^a   Rypackova B ^a   Prochazkova Z ^a   Kucera P ^a   Cerna M ^a   Andel M ^a   Heneberg, P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; GLUTAMATE DECARBOXYLASE 65; HEMOGLOBIN A1C; HLA ANTIGEN; PROTEIN TYROSINE PHOSPHATASE ISELT ANTIGEN 2; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CZECH REPUBLIC; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MALE; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET;

ADOLESCENT; ADULT; AGE OF ONSET; AUTOANTIBODIES; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOKINASE; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A, GLYCOSYLATED; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; YOUNG ADULT;

EID: 84896141306     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12314     Document Type: Article

References (27)

1. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335: 147-149.
2. van Deutekom AV, Heine RJ, Simsek S. The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet Med 2008; 25: 117-125.
3. Pietropaolo M, Barinas-Mitchell E, Pietropaolo SL, Kuller LH, Trucco M. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. Diabetes 2000; 49: 32-38.
4. de Leiva A, Dídac M, Corcoy R. Diabetes-related autoantibodies and gestational diabetes. Diabetes Care 2007; 30: S127-S133.
5. Kawasaki E, Abiru N, Yano M, Uotani S, Matsumoto K, Matsuo H, et al. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies. J Autoimmun 1995; 8: 633-643.
6. Leslie RDG, Atkinson MA, Notkins AL. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes. Diabetologia 1999; 42: 3-14.
7. Ortega-Rodriguez E, Levy-Marchal C, Guillermine S, Polak M. Beta-cell autoimmunity in a child with MODY (maturity-onset diabetes in the young). Diabetes Metab 2001; 27: 59-61.
8. Aguilera E, Casamitjana R, Ercilla G, Oriola J, Nicoletti F, Gomis R, et al. Clinical characteristics, β-cell function, HLA class II and mutations in MODY genes in non-paediatric subjects with Type 1 diabetes without pancreatic autoantibodies. Diabet Med 2005; 22: 137-143.
9. Bowden SA, Hoffman RP. Triple diabetes: coexistence of type 1 diabetes mellitus and a novel mutation in the gene responsible for MODY3 in an overweight adolescent. Pediatr Diabetes 2008; 9: 162-164.
10. Maltoni G, Zucchini S, Scipione M, Mantovani V, Salardi S, Cicognani A. Onset of type 1 diabetes mellitus in two patients with maturity onset diabetes of the young. Pediatr Diabetes 2012; 13: 208-212.
11. Calcaterra V, Martinetti M, Salina A, Aloi C, Larizza D. The coexistence of type 1 diabetes, MODY2 and metabolic syndrome in a young girl. Acta Diabetol 2012; 49: 401-404.
12. Urbanová J, Rypáčková B, Kučera P, Anděl M, Heneberg P. Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in MODY? The case of autoimmunity-associated destruction of pancreatic β-cells in a family of HNF1A-MODY subjects. Int Arch Allergy Immunol 2013; 161: 279-284.
13. Schober E, Rami B, Grabert M, Thon A, Kapellen T, Reinehr T et al. DPV-Wiss Initiative of the German Working Group for Paediatric Diabetology. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multi-centre database. Diabet Med 2009; 26: 466-473.
14. McDonald TJ, Colclough K, Brown R, Shields B, Shepherd M, Bingley P, et al. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes. Diabet Med 2011; 28: 1028-1033.
15. Borg H, Gottsäter A, Fernlund P, Sundkvist G. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 2002; 51: 1754-1762.
16. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, et al. for the UK Prospective Diabetes Study (UKPDS) Group. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 1997; 350: 1288-1293.
17. Naik RG, Palmer JP. Latent autoimmune diabetes in adults (LADA). Rev Endocr Metab Disord 2003; 4: 233-241.
18. Bazalová Z, Rypáčková B, Brož J, Brunerová L, Polák J, Rušavý Z, et al. Three novel mutations in MODY and its phenotype in three different Czech families. Diabetes Res Clin Pract 2010; 88: 132-138.
19. 1c-curve above the normal range and the prediction of microvascular outcomes: an analysis of data from the Diabetes Control and Complications Trial. Diabet Med 2013; 30: 95-99.
20. NCCLS. Protocols for the Determination of Limits of Detection and Limits of Quantification; Approved Guideline. NCCLS document EP17-A. Waynne, PA: NCCLS, 2004. Available at http://www.abrf.org/index.cfm?method=list.getAttachment&disclaimerAck=1&msg=83913&att=688 Last accessed 12 February 2013.
21. Černá M, Novota P, Kolostová K, Čejková P, Žďárský E, Nováková D, et al. HLA in Czech adult patiens with autoimmune diabetes mellitus: comparison with Czech children with type 1 diabetes and patients with type 2 diabetes. Eur J Immunogenet 2003; 30: 401-407.
22. Cinek O, Koloušková S, Šnajderová M, Šumník Z, Sedláková P, Dřevínek P, et al. HLA class II genetic association of type 1 diabetes mellitus in Czech children. Pediatr Diabetes 2001; 2: 98-102.
23. Uchizono Y, Baldwin AC, Sakuma H, Pugh W, Polonsky KS, Hara M. Role of HNF-1α in regulating the expression of genes involved in cellular growth and proliferation in pancreatic beta-cells. Diabetes Res Clin Pract 2009; 84: 19-26.
24. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004; 53: 16-21.
25. Mandrup-Poulsen T. Beta-cell apoptosis: stimuli and signaling. Diabetes 2001; 50: 58-63.
26. Němcová-Fürstová V, James RFL, Kovář J. Inhibitory effect of unsaturated fatty acids on saturated fatty acid-induced apoptosis in human pancreatic β-cells: activation of caspases and ER stress induction. Cell Physiol Biochem 2011; 27: 525-538.
27. Prentki M, Nolan CJ. Islet β-cell failure in type 2 diabetes. J Clin Invest 2006; 116: 1802-1812.